Nasopectra Nasal spray 120 doses
MDI Pharma
MDI Pharma
Composition (per 1 spray)
• Azelastine Hydrochloride – 137 mcg
• Fluticasone Propionate – 50 mcg.
Nasopectra is a combined nasal spray with anti-allergic and anti-inflammatory effects.
It is used to treat seasonal and perennial allergic rhinitis. Contains an antihistamine and a glucocorticosteroid, providing fast and long-lasting relief of allergy symptoms.
Pharmacological properties
Azelastine is a second-generation antihistamine that blocks H1-histamine receptors, reducing itching, sneezing, runny nose, and mucosal swelling.
Fluticasone is a synthetic glucocorticosteroid with pronounced anti-inflammatory, anti-allergic, and vasoconstrictive actions. It reduces inflammation in the nasal cavity, decreases mucus production, and eliminates swelling.
Combined use ensures a rapid onset of action (within 15 minutes) and a prolonged effect up to 24 hours.
Indications for use
• Seasonal allergic rhinitis
• Perennial allergic rhinitis
• Allergic rhinitis with nasal congestion, sneezing, itching, and rhinorrhea.
Dosage and administration
Adults and children over 12 years
• 1 spray into each nostril twice daily (morning and evening).
Shake the bottle well before use.
For best results, use regularly throughout the allergen exposure period.